搜索临床试验以:AIT滴剂
总计6939个结果
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
State University of New York at BuffaloAmerican Diabetes Association终止
-
Tomsk National Research Medical Center of the Russian...完全的冠状动脉疾病 | 冠状动脉搭桥术 | 体外循环 | 一氧化氮 | 再灌注损伤,心肌
-
Cantonal Hospital of St. GallenSwiss National Science Foundation; Swiss HIV Cohort Study终止
-
Merck Sharp & Dohme LLC完全的
-
Boehringer Ingelheim完全的2型糖尿病美国, 阿根廷, 奥地利, 捷克共和国, 爱沙尼亚, 芬兰, 法国, 德国, 匈牙利, 拉脱维亚, 挪威, 罗马尼亚, 俄罗斯联邦, 斯洛伐克, 西班牙, 乌克兰
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Washington University School of MedicineNational Cancer Institute (NCI); American Society of Clinical Oncology; ImmunityBio, Inc.; The Leukemia... 和其他合作者终止
-
National Cancer Institute (NCI)招聘中急性髓性白血病 | 既往骨髓增生异常/骨髓增生性肿瘤引起的急性髓性白血病 | 细胞毒治疗后急性髓系白血病 | 急性髓系白血病,骨髓增生异常相关美国, 波多黎各
-
Beijing Chest HospitalThe First Affiliated Hospital with Nanjing Medical University; Anhui Chest Hospital; Shenyang... 和其他合作者招聘中
-
Tomsk National Research Medical Center of the Russian...主动,不招人
-
University of AlbertaCanadian Institutes of Health Research (CIHR); University Hospital Foundation; Canadian Lung Association完全的
-
Hospital Italiano de Buenos AiresSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)未知
-
AbbVie (prior sponsor, Abbott)Biogen完全的
-
AbbVie (prior sponsor, Abbott)完全的
-
Cairo University邀请报名
-
Medstar Health Research InstituteSociety of Family Planning Research Fund完全的
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Ohio State University Comprehensive Cancer Center主动,不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性边缘区淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性非霍奇金淋巴瘤 | 难治性非霍奇金淋巴瘤 | 造血细胞移植受者 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 难治性转化惰性非霍奇金淋巴瘤美国
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢浆液性囊腺癌 | 卵巢未分化癌美国
-
Memorial Sloan Kettering Cancer CenterAscenta Therapeutics终止
-
Ascenta Therapeutics完全的
-
Hospital Israelita Albert EinsteinFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
HedgePath Pharmaceuticals, Inc.完全的